This study will assess the progression of RP as seen on newer modalities including spectral-domain optical coherence (SD-OCT) and macular assessment integrity (MAIA) microperimetry to evaluate disease status. Understanding the natural history of the disease is not only essential to monitoring and comparing patient populations in clinical trials. It is also fundamental in the predevelopment phase in order to optimize the study duration needed to observe a statistically significant outcome. Furthermore, since the progression of RP is usually slow, relying on traditional tests can take an unfeasible length of time to observe any meaningful changes and assess therapeutic efficacy for new drugs. Therefore, the results of this study will be beneficial in establishing reliable endpoints and outcome measures for future clinical trials. Such outcome measures may be able to detect treatment response with more precision. More importantly, investigators may be able to detect changes early enough to prevent irreversible vision loss.
Study Type
OBSERVATIONAL
Enrollment
32
Wilmer Eye Institute at Johns Hopkins University
Baltimore, Maryland, United States
Change in mean macular sensitivity (dB) over time as assessed by microperimetry
Microperimetry (MAIA) will be used to test whether there is a change in sensitivity (dB) in the macula
Time frame: Baseline, every six months up to 2 years
Change in Best Corrected Visual Acuity (BVCA)
Scoring will be determined by the number of letters gained or lost per month using Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score and visual acuity score together with an overall score range of 0 to 20/20 where 0 is the worst vision and 20/20 is the best.
Time frame: Baseline, every six months up to 2 years
Change in Ellipsoid Zone (EZ) width
This will be assessed by spectral domain optical coherence tomography (SD-OCT)
Time frame: Baseline, every six months up to 2 years
Change in Quality of Life survey metrics
Scoring will be determined by the National Eye Institute's Visual Function Questionnaire (NEI-VFQ-25). It has 25 question elements each with score ranging from 1(excellent) to 6(very poor), therefore a total minimum score of 25 and maximum score 150.
Time frame: Baseline, every year up to 2 years
Change in mean retinal sensitivity
Static Octopus Perimetry will be used to test whether there is a change in mean retinal sensitivity over time using its 30-2 program with III target
Time frame: Baseline and at 2 years
Correlation between change in visual functional and anatomical measures
Change in visual function parameters such as Best Corrected Visual acuity (measured using ETDRS and visual acuity scale), mean macular sensitivity (quantified using MAIA microperimetry), mean retinal sensitivity (quantified using static Octopus perimetry) will be correlated to anatomical parameters such as Ellipsoid width (measurement on Optical Coherence Tomography)
Time frame: Baseline, every six months up to 2 years
Correlation between change in visual functional measures and Quality of Life survey metrics
Change in Quality of Life survey metrics (Scored using National Eye Institute's Visual Function Questionnaire, NEI-VFQ-25) will be compared to visual function parameters such as Best Corrected Visual acuity (measured using ETDRS and visual acuity scale), mean macular sensitivity (quantified using MAIA microperimetry), mean retinal sensitivity (quantified using static Octopus perimetry)
Time frame: Baseline, every year up to 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.